Deficient response of IL-6 impaired liver regeneration after hepatectomy in patients with viral hepatitis

Hepato-Gastroenterology

Volumn 55, Issue 85, 2008, Pages 1439-1444

  Gotohda, Naoto ^a   Iwagaki, Hiromi ^b   Ozaki, Michitaka ^c   Kinoshita, Taira ^a   Konishi, Masaru ^a   Nakagohri, Toshio ^a   Takahashi, Shinichiro ^a   Saito, Shinya ^b   Yagi, Takahito ^b   Tanaka, Noriaki ^b  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hepatocyte growth factor; Interleukin 6; Liver regeneration; Soluble interleukin 6 receptor; Viral hepatitis

Indexed keywords

CYTOKINE RECEPTOR; HGF PROTEIN, HUMAN; INTERLEUKIN 6; SCATTER FACTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

AGED; ARTICLE; BLOOD; CARCINOMA; COHORT ANALYSIS; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; LIVER REGENERATION; LIVER RESECTION; LIVER TUMOR; MALE; MIDDLE AGED; PHYSIOLOGY; VIROLOGY;

AGED; CARCINOMA; COHORT STUDIES; FEMALE; HEPATECTOMY; HEPATITIS B, CHRONIC; HEPATITIS C, CHRONIC; HEPATOCYTE GROWTH FACTOR; HUMANS; INTERLEUKIN-6; LIVER NEOPLASMS; LIVER REGENERATION; MALE; MIDDLE AGED; RECEPTORS, CYTOKINE; TUMOR NECROSIS FACTORS;

EID: 58149393047     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Michalopoulos GK, DeFrances MC: Liver regeneration. Science 1997; 276:60-66.
2. Streetz KL, Luedde T, Manns MP, Trautwein C: Interleukin 6 and liver regeneration. Gut 2000; 47:309-312.
3. Zimmers TA, McKillop IH, Pierce RH, Yoo JY, Koniaris LG: Massive liver growth in mice induced by systemic interleukin 6 administration. Hepatology 2003; 38:326-334. (Pubitemid 36919853)
4. Baiocchi M, Marcucci I, Rose-John S, Serlupi Crescenzi O, Biffoni M: An IL-6/IL-6 soluble receptor (IL-6R) hybrid protein (H-IL-6) induces EPO-independent erythroid differentiation in human CD34(+) cells. Cytokine 2000; 12:1395-1399.
5. Galun E, Zeira E, Pappo O, Peters M, Rose-John S: Liver regeneration induced by a designer human IL-6/sIL-6R fusion protein reverses severe hepatocellular injury. FASEB J. 2000; 14:1979-1987.
6. Bowman T, Garcia R, Turkson J, Jove R: STATs in oncogenesis. Oncogene 2000; 19:2474-2488. (Pubitemid 30339203)
7. Hirano T, Ishihara K, Hibi M: Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 2000; 19:2548-2556. (Pubitemid 30339210)
8. Haga S, Terui K, Zhang HQ, Enosawa S, Ogawa W, Inoue H, Okuyama T, Takeda K, Akira S, Ogino T, Irani K, Ozaki M: Stat3 protects against Fas-induced liver injury by redox-dependent and -independent mechanisms. J Clin Invest 2003; 112:989-998. (Pubitemid 38056314)
9. Taub R: Hepatoprotection via the IL-6/Stat3 pathway. J Clin Invest 2003; 112:978-980.
10. Okano J, Shiota G, Kawasaki H: Expression of hepatocyte growth factor (HGF) and HGF receptor (c-met) proteins in liver diseases: an immunohistochemical study. Liver 1999; 19:151-159. (Pubitemid 29139769)
11. Kaibori M, Inoue T, Oda M, Naka D, Kawaguchi T, Kitamura N, Miyazawa K, Kwon AH, Kamiyama Y, Okumura T: Exogenously administered HGF activator augments liver regeneration through the production of biologically active HGF. Biochem Biophys Res Commun 2002; 290:475-481. (Pubitemid 34694525)
12. Ozaki M, Haga S, Zhang HQ, Irani K, Suzuki S: Inhibition of hypoxia/reoxygenation-induced and rac1-regulated oxidative stress in HGF-stimulated anti-apoptotic signaling: role of PI3-K and Akt kinase. Cell Death Differ 2003; 10:508-515. (Pubitemid 36656640)
13. Peters M, Blinn G, Jostock T, Schirmacher P, Meyer zum Buschenfelde KH, Galle PR, Rose-John S: Combined interleukin 6 and soluble interleukin 6 receptor accelerates murine liver regeneration. Gastroenterology 2000; 119:1663-1671. (Pubitemid 32198692)
14. Trautwein C, Rakemann T, Niehof M, Rose-John S, Manns MP: Acute-phase response factor, increased binding, and target gene transcription during liver regeneration. Gastroenterology 1996; 110:1854-1862. (Pubitemid 26000010)
15. Ueda T, Sakabe T, Oka M, Maeda Y, Nishida M, Murakami F, Maekawa T: Levels of interleukin (IL)-6, IL-8 and IL-1 receptor antagonist in the hepatic vein following liver surgery. Hepatogastroenterology 2000; 34:1048-1051.
16. Kim YI, Song KE, Ryeon HK, Hwang YJ, Yun YK, Lee JW, Chun BY: Enhanced inflammatory cytokine production at ischemia/reperfusion in human liver resection. Hepatogastroenterology 2002; 46:1077-1082.
17. Taga T, Hibi M, Hirata Y, Yamasaki K, Yasukawa K, Matsuda T, Hirano T, Kishimoto T: Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell 1989; 58:573-581. (Pubitemid 19203542)
18. Hibi M, Murakami M, Saito M, Hirano T, Taga T, Kishimoto T: Molecular cloning and expression of an IL-6 signal transducer, gp130. Cell 1990; 63:1149-1157. (Pubitemid 120035064)
19. Maione D, Di Carlo E, Li W, Musiani P, Modesti A, Peters M, Rose-John S, Delia Rocca C, Tripodi M, Lazzaro D, Taub R: Coexpression of IL-6 and soluble IL-6R causes nodular regenerative hyperplasia and adenomas of the liver. EMBO J 1998; 17:5588-5597. (Pubitemid 28445970)
20. Wustefeld T, Rakemann T, Kubicka S, Manns MP, Trauwein C: HyperStimulation with interleukin 6 inhibits ceU cycle progression after hepatectomy in mice. Hepatology 2000; 32:514-522.
21. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 1991; 66:233-243. (Pubitemid 121001362)
22. Kiba T, Saito S, Numata K, Sekihara H: Fas (APO-1/CD95) mRNA is down-regulated in liver regeneration after hepatectomy in rats. J Gastroenterol 2000; 35:34-38. (Pubitemid 30072278)
23. Xia M, Xu C, Ji S, Xue S: Shedding of Fas ectodomain that affects apoptosis of hepatocytes occurring in regenerative liver. J Gastroenterol 2002; 37:1042-1047. (Pubitemid 36105023)
24. Tanaka M, Suda T, Haze K, Nakamura N, Sato K, Kimura F, Motoyoshi K, Mizuki M, Tagawa S, Ohga S, Hatake K, Drummond AH, Nagata S: Fas ligand in human serum. Nature Med 1996; 2:317-322. (Pubitemid 26080652)
25. Kayagaki N, Kawasaki A, Ebata T, Ohmoto H, Ikeda S, Inoue S, Yoshino K, Okumura K, Yagita H: Metalloproteinase-mediated release of human Fas ligand. J Exp Med 1995; 182:1777-1783.
26. Nagata S: Apoptosis by death factor. Cell 1997; 88:355-365.
27. Hengartner MO: The biochemistry of apoptosis. Nature 2000; 497:770-776.
28. Watanabe R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by detects in Fas antigen that mediates apoptosis. Nature 1992; 356:314-317.
29. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 1995; 267:1456-1462.
30. Nishizaki K, Minatoguchi S, Seishima M, Asano K, Noda T, Yasuda N, Sano H, Kumada H, Takemura M, Noma A, Tanaka T, Watanabe S, Fujiwara H: Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure. J Am Coll Cardiol 1997; 29:1214-1220. (Pubitemid 27201937)
31. Yoneyama K, Goto T, Miura K, Mikami K, Ohshima S, Nakane K, Lin JG, Sugawara M, Nakamura N, Shirakawa K, Komatsu M, Watanabe S: The expression of Fas and Fas hgand, and the effects of interferon in chronic liver diseases with hepatitis C virus. Hepatology Research 2002; 24:327-337. (Pubitemid 36004141)
32. Iio S, Hayashi N, Mita E, Ueda K, Mochizuki K, Hiramatsu N, Kanto T, Sasaki Y, Kasahara A, Hori M: Serum levels of soluble Fas antigen in chronic hepatitis C patients. J Hepatol 1998; 29:517-523. (Pubitemid 28484939)